1. 40P Can we predict which TIL products will react against NSCLC tumours based on the immune infiltrates?. (December 2022) Authors: Castenmiller, S.; Kanagasabesan, N.; de Groot, R.; Guislain, A.; van Loenen, M.; Monkhorst, K.; Hartemink, K.; Klomp, H.M.; Smit, E.; Haanen, J.B.A.G.; Wolkers, M. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Benzo[a]pyrene induced regulation of mRNA translation and its impact on gene expression. (10th October 2018) Authors: Smit, E.; Caiment, F.; Piepers, J.; Kleinjans, J.C.S.; van den Beucken, T. Journal: Toxicology letters Issue: Volume 295(2018)Supplement 1 Page Start: S217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Brigatinib in crizotinib-refractory ALK+ non-small cell lung cancer (NSCLC): efficacy updates and exploratory analysis of target lesion response by baseline brain lesion status in the ALTA Trial. (January 2019) Authors: Kim, D.; Huber, R.; Ahn, M.; Langer, C.; Tiseo, M.; West, H.; Groen, H.; Reckamp, K.; Hochmair, M.; Leighl, N.; Hansen, K.H.; Gettinger, S.; Paz-Ares Rodriguez, L.; Kim, E.; Smit, E.; Kim, S.; Reichmann, W.; Kerstein, D.; Camidge, D.R. Journal: Lung cancer Issue: Volume 127(2019)Supplement 1 Page Start: S30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EP-1366: Different toxicity rating patients and physicians in randomized phase III PCI vs obs stage III NSCLC. (April 2018) Authors: De Ruysscher, D.; Dingemans, A.; Praag, J.; Belderbos, J.; Tissing-Tan, C.; Herder, G.; Haitjema, T.; Ubbels, F.; Lagerwaard, F.; Stigt, J.; Smit, E.; Van Tinteren, H.; Van der Noort, V.; Groen, H. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S745 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Evaluation of the role of Care Sport Connectors in connecting primary care, sport, and physical activity, and residents' participation in the Netherlands: study protocol for a longitudinal multiple case study design. (December 2015) Authors: Smit, E.; Leenaars, K.E.F.; Wagemakers, M.A.E.; Molleman, G.R.M.; Koelen, M.A.; van der Velden, J. Journal: BMC public health Issue: Volume 15:Number 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Identification of essential transcription factor networks during genotoxic stress response using functional genomics. (16th September 2016) Authors: Smit, E.; Souza, T.M.; Jennen, D.G.; Kleinjans, J.C.; Van Den Beucken, T. Journal: Toxicology letters Issue: Volume 258(2016)Supplement Page Start: S241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Objectively measured physical activity and C‐reactive protein: National Health and Nutrition Examination Survey 2003–2004. Issue 2 (3rd August 2011) Authors: Loprinzi, P.; Cardinal, B.; Crespo, C.; Brodowicz, G.; Andersen, R.; Sullivan, E.; Smit, E. Journal: Scandinavian journal of medicine & science in sports Issue: Volume 23:Issue 2(2013) Page Start: 164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Optimising translational oncology in clinical practice: Strategies to accelerate progress in drug development. Issue 2 (February 2015) Authors: Stahel, R.; Bogaerts, J.; Ciardiello, F.; de Ruysscher, D.; Dubsky, P.; Ducreux, M.; Finn, S.; Laurent-Puig, P.; Peters, S.; Piccart, M.; Smit, E.; Sotiriou, C.; Tejpar, S.; Van Cutsem, E.; Tabernero, J. Journal: Cancer treatment reviews Issue: Volume 41:Issue 2(2015) Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Outcomes and costs of single-step hepatitis C testing in primary care, Birmingham, United Kingdom. (January 2019) Authors: Munang, M.; Smit, E.; Barnett, T.; Atherton, C.; Tahir, M.; Atabani, S.F. Journal: Public health Issue: Volume 166(2019) Page Start: 40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Prevention of Chemotherapy-induced Myelosuppression in SCLC patients treated with the Dual MDMX/MDM2 Inhibitor ALRN-6924. (October 2020) Authors: Andric, Z.; Ceric, T.; Stanetic, M.; Rancic, M.; Jakopovic, M.; Aix, S. Ponce; Ramlau, R.; Smit, E.; Ulanska, M.; Caldwell, C.; Ferrari, D.; Annis, A.; Vukovic, V.; Zaric, B. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗